Bigfoot Biomedical, Inc.
Bigfoot Biomedical is a company dedicated to transforming diabetes care through innovative, connected insulin management solutions. They focus on holistic insulin therapy, leveraging services, support, and novel business models. Their mission includes expanding insulin access, supporting better health outcomes, and reducing the burden of diabetes management for people with insulin-requiring diabetes. They collaborate with healthcare providers, payers, and other stakeholders to deliver simple, connected, and comprehensive solutions, including the Bigfoot Unity Diabetes Management System and the upcoming Bigfoot Unity system compatible with multiple insulin products and devices.
Industries
Nr. of Employees
medium (51-250)
Bigfoot Biomedical, Inc.
1820 McCarthy Blvd, Milpitas, CA 95035
Patents
Devices, systems, and methods for estimating active medication from injections
US-12343495-B2
View DetailsTherapy assist information and/or tracking device and related methods and systems
US-12290667-B2
View DetailsSystems and methods for monitoring use of and ensuring continuity of functionality of insulin infusion pumps, glucose monitors, and other diabetes treatment equipment
US-12283357-B2
View Details
Devices, systems, and methods for estimating active medication from injections
US-12343495-B2
View DetailsTherapy assist information and/or tracking device and related methods and systems
US-12290667-B2
View DetailsSystems and methods for monitoring use of and ensuring continuity of functionality of insulin infusion pumps, glucose monitors, and other diabetes treatment equipment
US-12283357-B2
View DetailsProducts
Connected insulin management system (pen-cap hardware, mobile app, cloud portal)
Integrated system pairing connected pen-cap hardware with a patient mobile application and a cloud-based clinician portal to provide CGM-informed insulin dose recommendations, automatic capture of injection events, and remote clinician oversight for people using multiple daily injections.
Connected insulin management system (pen-cap hardware, mobile app, cloud portal)
Integrated system pairing connected pen-cap hardware with a patient mobile application and a cloud-based clinician portal to provide CGM-informed insulin dose recommendations, automatic capture of injection events, and remote clinician oversight for people using multiple daily injections.
Services
Online portal for healthcare professionals to review patient dosing and glucose data, manage therapy settings, and support remote care and population management workflows.
Sponsor-led clinical trial execution and retrospective real-world data analyses to generate safety, usability, and outcome evidence for connected insulin management systems.
Qualification programs to validate interoperability of connected injection hardware and software with third-party CGM sensors, insulin formulations, and disposable pen/needle products.
Online portal for healthcare professionals to review patient dosing and glucose data, manage therapy settings, and support remote care and population management workflows.
Sponsor-led clinical trial execution and retrospective real-world data analyses to generate safety, usability, and outcome evidence for connected insulin management systems.
Qualification programs to validate interoperability of connected injection hardware and software with third-party CGM sensors, insulin formulations, and disposable pen/needle products.
Expertise Areas
- Insulin dose decision support for multiple daily injection therapy
- Automated insulin delivery and closed-loop control
- Connected injection devices and IoT-enabled device ecosystems
- Mobile health applications and cloud-based clinician platforms
Key Technologies
- Continuous glucose monitoring (CGM) integration
- Connected pen-cap hardware with local display and dose capture
- Mobile health applications (iOS, Android)
- Cloud-based clinician portals and remote management
News & Updates
Bigfoot Biomedical was showcased at Google I/O 2018 as a use case demonstrating Android security features for connected medical devices.
Bigfoot enrolled its first patients in a clinical trial for the smartloop automated insulin delivery system.
Abbott announced the completion of its acquisition of Bigfoot Biomedical, expanding its diabetes care portfolio.
Bigfoot was recognized by Fast Company as one of the world's most innovative companies in 2023.
Named as one of the 'World’s Most Innovative Companies' in 2023 for its Bigfoot Unity Diabetes Management System.
Bigfoot Biomedical was showcased at Google I/O 2018 as a use case demonstrating Android security features for connected medical devices.
Bigfoot enrolled its first patients in a clinical trial for the smartloop automated insulin delivery system.
Abbott announced the completion of its acquisition of Bigfoot Biomedical, expanding its diabetes care portfolio.
Bigfoot was recognized by Fast Company as one of the world's most innovative companies in 2023.
Named as one of the 'World’s Most Innovative Companies' in 2023 for its Bigfoot Unity Diabetes Management System.